DS, H., JR, P., BG, T., JL, F., JS, H., EH, P., & VI, A. (2004). Asparaginase pharmacokinetics after intensive polyethylene glycol-conjugated L-asparaginase therapy for children with relapsed acute lymphoblastic leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research, 10(16), 5335. https://doi.org/10.1158/1078-0432.CCR-04-0222
Chicago Style (17th ed.) CitationDS, Hawkins, Park JR, Thomson BG, Felgenhauer JL, Holcenberg JS, Panosyan EH, and Avramis VI. "Asparaginase Pharmacokinetics After Intensive Polyethylene Glycol-conjugated L-asparaginase Therapy for Children with Relapsed Acute Lymphoblastic Leukemia." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 10, no. 16 (2004): 5335. https://doi.org/10.1158/1078-0432.CCR-04-0222.
MLA (9th ed.) CitationDS, Hawkins, et al. "Asparaginase Pharmacokinetics After Intensive Polyethylene Glycol-conjugated L-asparaginase Therapy for Children with Relapsed Acute Lymphoblastic Leukemia." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 10, no. 16, 2004, p. 5335, https://doi.org/10.1158/1078-0432.CCR-04-0222.